Originally posted by ParkTwain
View Post
This is a great deal for HTI. They're getting between 20M and 100M from Roche to develop their delivery technology (and possibly a whole lot more, if it actually works), as well as a 5% equity purchase. This gives them an enormous benefit in having that partner to back them up along the way. Of course a lot of that is reflected in the jump in price from $2 to $6, but the price is still climbing, and it may be worth a stab at riding it up to the next level (8 or 10?). I don't think I'd put any long-term investment in HTI just based on this PR, but definitely wish I'd heard about this earlier, like Wednesday... I still might look at this as a potential play for next week. Thanks for bringing it to my attention, Park!
The company itself seems a bit on the light side- just 37 people according to Yahoo... I bet that's changed or will change shortly with the new money coming in. For a 40 person company there do seem to be quite a few of them making some decent pocket change (at least 4 at 200k+ listed):
But at least they appear to be financially sound, only losing a couple million or so each quarter in cash, with about $20M left in the bank. As long as they keep the stock price up, they should be able to keep the lights on for a long time- and the Roche deal should be just the ticket for them.


Cool!
Leave a comment: